Dilon Technologies, Inc.

Dilon Technologies, Inc. is a medical device manufacturer specializing in women's healthcare and surgical innovation, with over 20 years of experience and presence in 76+ countries. The company develops and manufactures advanced diagnostic and surgical devices, with a primary focus on breast cancer detection and treatment optimization. Their core product portfolio includes MarginProbe®, a real-time margin assessment system for breast-conserving surgery that reduces re-excision rates; HEMOBLAST® Bellows, a combination powdered surgical hemostat containing thrombin, collagen, and chondroitin sulfate for intraoperative hemostasis; Navigator™ 2.0, a lightweight radio-guided surgical system for sentinel lymph node identification; TrueView 200 Pro, an advanced radiography and automated software system for precise tumor lesion identification in resected tissue specimens; Navigator Sterilization, a sterilizable stainless steel gamma probe designed to reduce cross-contamination; and CoPilot VL+®, a portable video laryngoscope for intubation procedures. The company has expanded into biosurgery with emphasis on improving surgical outcomes and reducing operative complications. Dilon serves hospitals, surgical centers, and healthcare providers globally, with demonstrated clinical evidence supporting cost savings and improved patient outcomes. The company maintains manufacturing and distribution capabilities, with a secondary manufacturing presence in Israel.